Goldman Sachs: Morgan Stanley raises target price to $1,145 from $1,099
GS•Related News
Berkshire Hathaway <BRKa.N>: TD Cowen raises target price to $792,000 from $721,000
BRK.A•
Unicycive Therapeutics posts corporate presentation on kidney disease drug pipeline, led by OLC for dialysis hyperphosphatemia
UNCY•
Spyre Therapeutics Inc <SYRE.O>: Baird assumes coverage with outperform rating; target price $120
SYRE•
Alphabet eyes inaugural Australia dollar bond, announcement shows
GOOGL•
Mesoblast completes dosing in Phase 3 rexlemestrocel-L trial for chronic low back pain
MESO•